Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

ExpertiseUpdated on 25 February 2026

Oxeltis _ Bridge the gap between biology and chemical matter...

Christophe Parsy

Business & Strategic Development Director at Oxeltis

Montpellier, France

About

We address this by:

Seamless integration of in silico design (CADD, SBDD, LBDD, AI/ML) in partnership with Molecular Forecaster (Montreal) and Assay development/in vitro biological screening in partnership with Partex.AI Labs

Rapid hit-to-lead and lead optimization, with a track record of delivering high-quality compounds efficiently and a highly skill team of chemists (50% Ph.D., 50% M.Sc.)

Expertise in complex and enabling chemistries, supported by our hybrid SFC platform for rapid purification and scale-up (up to 25g/day) of chiral/achiral mixtures.

Oxeltis, France-based CRO specialized in medicinal and fine organic chemistry can support early small molecule drug disocvery programs to mature at Hit to Lead and Lead optimization stage.

Field

  • Biotech, Pharma and Cosmetics

Organisation

Oxeltis

SME

Montpellier, France

Similar opportunities